Understanding and Diagnosing Allergic Disease in Twins
1 other identifier
observational
340
1 country
2
Brief Summary
The purpose of this study is to gain better understanding of how the immune system works in twins with and without allergic disease. Healthy volunteers are not specifically targeted. Healthy non-allergic study participants may be found through the course of evaluation for the presence of allergies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2010
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 5, 2012
CompletedFirst Posted
Study publicly available on registry
June 7, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedMarch 17, 2021
March 1, 2021
9.2 years
June 5, 2012
March 15, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Comparing immune systems of food allergic twins
Differences in genetic and phenotypic characteristics between twin siblings
2 years
Study Arms (1)
Twins
Twins that are ages 0 to 80 years, with or without allergy disease.
Interventions
This study does not involve any intervention other than obtaining blood, nasal/cheek/throat/skin swabs, saliva, sputum, urine, and stool samples, breathing and skin tests.
Eligibility Criteria
Healthy volunteers are not specifically targeted. Healthy non-allergic study participants may be found through the course of evaluation for the presence of allergies. Women, minorities or children will not be excluded from this study.
You may qualify if:
- Twin participants ages 0 to 80 years who are with or without allergy disease.
You may not qualify if:
- Patients with special risks attendant to venipuncture will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Sean N Parker Center for Allergy and Asthma Research at Stanford
Stanford, California, 94305, United States
Stanford University School of Medicine
Stanford, California, 94305, United States
Related Publications (1)
Bao R, Hesser LA, He Z, Zhou X, Nadeau KC, Nagler CR. Fecal microbiome and metabolome differ in healthy and food-allergic twins. J Clin Invest. 2021 Jan 19;131(2):e141935. doi: 10.1172/JCI141935.
PMID: 33463536DERIVED
Biospecimen
Blood, nasal /cheek/throat/skin swab, saliva, urine, stool, sputum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kari Nadeau, MD, PhD
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 5, 2012
First Posted
June 7, 2012
Study Start
August 1, 2010
Primary Completion
October 1, 2019
Study Completion
October 1, 2019
Last Updated
March 17, 2021
Record last verified: 2021-03